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Abstract
Japanese encephalitis (JE) virus is the most common cause of epidemic viral encephalitis in the world. The virus
mainly infects neuronal cells and causes an inflammatory response after invasion of the parenchyma of the brain.
The death of neurons is frequently observed, in which demyelinated axons are commonly seen. The mechanism
that accounts for the occurrence of demyelination is ambiguous thus far. With a mouse model, the present study
showed that myelin-specific antibodies appeared in sera, particularly in those mice with evident symptoms.
Meanwhile, specific T cells proliferating in response to stimulation by myelin basic protein (MBP) was also shown in
these mice. Taken together, our results suggest that autoimmunity may play an important role in the destruction
of components, e.g., MBP, of axon-surrounding myelin, resulting in demyelination in the mouse brain after infection
with the JE virus.
Background
Japanese encephalitis (JE) is a significant mosquito-borne
viral disease that causes a great number of encephalitic
epidemics particularly in Asian countries [1]. The JE
virus is a member of the Flavivirus, belonging to the
family Flaviviridae; the genome is composed of single-
stranded, positive-sense RNA of approximately ~11,000
nucleotides in length, and contains a single open reading
frame (ORF) that encodes 10 proteins including 3 struc-
tural and 7 non-structural ones [2]. In general, JE viral
infection is estimated to cause about a 25%~30% case-
fatality rate [3]. More importantly, permanent neuropsy-
chiatric sequelae related to JE are reported to appear in
up to 50% of survivors [4].
The JE virus, through mosquito bites, is hypothetically
amplified in dermal tissues and then lymph nodes via
migration of dendritic (Langerhans) cells prior to inva-
sion of the central nervous system (CNS) [5]. In most
cases, JE patients clinically appear as having encephalo-
myelitis involving the cortex, subcortex, brainstem, and
spinal cord [4,6], mostly presenting with such clinical
symptoms as headaches, vomiting, an altered mental
state, as well as dystonia, rigidity, and a characteristic
mask-like facies [7]. Surviving patients may slowly regain
neurological function over several weeks despite only
one-third of cases recovering normal neurological func-
tions [8]. Meanwhile, a proportion of them may exhibit
clinical sequelae including motor weakness, intellectual
impairment, and seizure disorders [3,4]. Specifically,
intellectual involvement is noted in 30% of cases, speech
disturbance in 34%, and motor deficits in 49% of such
patients [8]. It was reported that the JE virus enters the
CNS by way of an impaired blood-brain barrier (BBB)
[9], presumably carried by infected peripheral blood
mononuclear lymphocytes (PBMCs) [10,11].
In the CNS of JE patients, the virus may infect a variety
of brain tissues with a characteristic pattern of mixed
intensity or hypodense lesions including the thalamus,
basal ganglia, and midbrain [6]. Clinically, movement dis-
orders are frequently shown in patients who survive the
acute phase of JE [12], implying that sensorimotor neuro-
pathy eventually occurs. It is now known that encephalitis
associated with flaviviral infections may cause Guillain-
Barré-like syndrome, showing a demyelinating feature in
sensorimotor tissues of the brain [13]. This suggests that
demyelination is an important step causing disruption of
motor coordination during viral infection [14].
Either necrosis or apoptosis causes death of neurons
infected by encephalitic arthropod-borne viruses [15,16].
In addition, acute neuronal apoptosis was connected to
inflammatory and demyelinating disease of the CNS in a
rat model of multiple sclerosis [17]. In fact, we previously
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mouse brain infected by the JE virus. Nevertheless, how
demyelination occurs in brains infected with this virus
remains ambiguous. In this study, we provide experimen-
tal evidence showing the role of immune responses in the
occurrence of demyelination. This provided insights for
further understanding of the pathogenesis of JE virus
infection, especially in terms of movement disorders.
Methods
Virus and animals
The T1P1 strain of the JE virus used in this study is a
local strain from Taiwan; it was isolated from the mos-
quito, Armigeres subalbatus [18]. The virus was propa-
g a t e di nC 6 / 3 6c e l l s ,a n dt i t r a t e dw i t hB H K - 2 1c e l l sb y
means of plaque assays following the description in one
of our previous reports [19]. In total, 21 female ICR
mice at 4~6 weeks old were used in this study. Mice in
the study group were intravenously injected with a dose
o f1×1 0
6 plaque-forming units (PFU)/mouse of a viral
suspension diluted with phosphate-buffered saline (PBS,
pH 7.4) to a final volume of 100 μl. Those mice used as
the control were inoculated with a virus-free solution
diluted with cell culture medium. The movements and
body coordination of inoculated mice were monitored
daily for 3 wk. Mice with or without evident symptoms
(movement disorders, mostly rigidity of the hindlimbs)
were sacrificed to harvest serum samples for serological
investigations and brain tissues for light and electron
microscopy.
Frozen sectioning
Brain tissues were dissected out from mice inoculated
with and without the virus suspension. A part of the
brain was prepared for frozen sectioning to investigate
the histopathology and immunohistochemistry; the other
part was used for a virological examination. For frozen
sectioning, brain tissues embedded in tissue-freezing
medium (Jung, Nussloch, Germany) were transiently
frozen in liquid nitrogen and cut with a cryomicrotome
(CM3050S; Leica, Mannheim, Germany). Sections
7~8 μm thick were collected and placed on slides coated
with Silane S (Muto Pure Chemicals, Tokyo, Japan), then
fixed in cold acetone for 15 min before being stained.
Hematoxylin and eosin (H&E) staining
Frozen sections placed on slides were fixed in 24% for-
malin for 30 s and then washed with distilled water.
Sections were subsequently stained with hematoxylin for
1 min. After being washed with distilled water, sections
were dipped in 0.25% ammonia for 10 s and subse-
quently stained with eosin for 20 s after another wash
with distilled water. Sections were then dehydrated with
95% and absolute ethanol in sequence. Sections were
subsequently infiltrated with xylene and mounted in
Entellan
® (EMS, Hatfield, PA, USA).
Luxol fast blue staining
This staining protocol is used to stain myelin/myeli-
nated axons. The approach for staining in this study fol-
lowed a previously described method [20]. Briefly,
frozen sections were immersed in 95% alcohol for 5 min
before being stained with a 0.1% Luxol blue solution
and a 0.1% Cresyl echt violet solution. The results show
deep blue for myelin, violet for nuclei, and pale green
for erythrocytes.
Electron microscopy
Brain tissues dissected from mice were immediately
fixed with 2% (v/v) glutaraldehyde in 0.1 M cacodylate
buffer overnight at 4 °C. Tissues were subsequently
postfixed in 1% (w/v) osmium tetroxide in 0.1 M caco-
dylate buffer for 2 h at room temperature and then
washed with 0.2 M cacodylate buffer 3 times. After
washing, tissues were dehydrated through an ascending
graded series of ethanol and ultimately were embedded
in Spurr’s resin (EMS) and polymerized at 70°C for
72 h. Trimmed tissue blocks were sectioned with an
ultramicrotome (Reichert Ultracut R, Leica, Vienna,
Austria). Thin sections were sequentially stained with
saturated uranyl acetate in 50% ethanol and 0.08% lead
citrate. Selected images were observed and photo-
graphed under an electron microscope (JEOL JEM-1230,
Tokyo, Japan) at 100 kV.
Reverse-transcriptase polymerase chain reaction (RT-PCR)
Brain tissues were homogenized with minimum essential
medium (MEM), from which RNA was extracted using
the Trizol
® reagent (Invitrogen, Carlsbad, CA). Primers
and reaction conditions used for the subsequent RT-
PCR are described in our previous report.
11 The PCR
product was a ~291-bp fragment of the envelope (E)
protein of the JE virus, that could be seen by electro-
phoresis on a 2% (w/v) agarose gel containing 10 μl
ethidium bromide (1 mg/ml in RNase-free water).
Enzyme-linked immunosorbent assay (ELISA)
An indirect ELISA was used to detect specific MBP
immunoglobulin G (IgG) antibodies in this study. Initi-
ally, 5 μlo fm o u s eM B P( S i g m a ,S t .L o u i s ,M O ,U S A )
was coated on 96-well ELISA plates, followed by blocking
with 1% bovine serum albumin (BSA). Mouse serum
diluted to 1:50 in 1% BSA was added to each well of the
plates. After the plates were washed, a sheep anti-mouse
IgG antibody conjugated with horseradish peroxidase
(HRP) (GE Healthcare, Piscataway, NJ, USA) diluted to 1:
2000 in 1% BSA was added to the wells. After another
wash, the ABTS peroxidase substrate (KPL, Gaithersburg,
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10~15 min. Optical density (OD) values of each well of
the plates were read at a wavelength of 405 nm.
Isolation of splenocytes
To isolate splenocytes, dissected spleens were placed in
a 6-cm dish filled with RPMI culture medium (GIBCO
®,
Grand Island, NY, USA) containing 10% fetal calf serum
(FCS), 1% antibiotic-antimycotic (GIBCO
®), and 50 mM
2-mercaptoethanol (2-ME) (Sigma). The spleen was sub-
sequently disaggregated with a 23G needle to separate
splenocytes which were moved into a 50-ml centrifuge
tube and then centrifuged at 3000 rpm and 4°C for
10 min. After discarding the supernatant, erythrocytes
in the pellet were removed by hypotonic lysis with 1 ml
H2O. Splenocytes in the pellet were resuspended in
7 ml PBS. After centrifugation, the supernatant was dis-
carded. Then, 10 ml of Earle’s balanced salt solution
(EBSS) (Biological Industries, Beit Haemek, Israel) was
added to the tube for further centrifugation. Sub-
sequently, RPMI culture medium was added to the tube
to replace the supernatant. Ultimately, numbers of iso-
lated splenocytes were counted with a hematocytometer.
T cell proliferation
Splenocytes isolated from mice were cultured (2 × 10
5
cells/well) with RPMI medium. In total, 50 μg/ml mouse
MBP was added to each well of the plates, incubated at
37°C with a 5% CO2 atmosphere for 72 h, and then
pulsed with 1 μCi [
3H]-thymidine (Perkin Elmer,
Waltham, MA, USA) for 18 h before being harvested.
Radioactivity was determined directly in the plate with a
b-counter (TopCount, NXT™, Packard Instrument Co.,
Meriden, CT, USA). Proliferation was expressed as a sti-
mulation index (SI) that was estimated by a ratio of
counts in each well cultured with the MBP antigen over
that cultured with MBP-free medium.
Statistical analysis
Comparisons of the two means were analyzed by Stu-
dent’s t-test at a significance level of 5%.
Results
Detection of JE virus in the mouse brain
Five mice were chosen to detect viral RNA extracted
from either the cerebrum or cerebellum. Two (m1 and
m2) with evident symptoms and one with slight symp-
toms (m4) were detected to be positive except for the
cerebellum of m4. Both parts of the brain in a control
and one inoculated mouse with extremely slight symp-
toms were found to be negative. Those positive for viral
RNA always showed higher amounts of viral RNA in
the cerebrum that in the cerebellum (Figure 1).
Pathologic features of the mouse brain with JE viral
infection
Hindlimbs of inoculated mice with symptoms frequently
appeared paralytic, an important sign of infection by JE
virus in mice. In general, severe inflammation usually
occurred as shown in the brain of JE virus-inoculated
mice. Histological evidence showed that vessels were
frequently congested by increased numbers of inflamma-
tory cells in and around capillaries of the brain, particu-
larly the cerebrum (Figure 2A). Degenerating neurons
were commonly seen in the brain of symptomatic mice;
they were usually engulfed and were removed by phago-
cytes (Figure 2B). Numerous demyelinating axons were
primarily distributed in the cerebrum of symptomatic
mice (Figure 3A), where demyelination presented a
loose composition of myelin (Figure 3B). In contrast,
normal axons were surrounded by the myelin sheath
that was condensed with intraperiodic lines (Figure 3C).
MBP-specific antibody in sera of JE virus-infected mice
Among 21 mice chosen in this experiment for inocula-
tion with a JE viral suspension, 15 were asymptomatic
Figure 1 D e t e c t i o no fv i r a lR N Ab yR T - P C Ri nb r a i n so fm i c e
inoculated with Japanese encephalitis virus. The size of the
amplified fragment was estimated to be 291 bp. Viral RNA was
observed in all mice with evident clinical symptoms (m1, m2, and
m4). A mouse (c1) inoculated with culture medium was used as the
control. In addition, viral RNA was detected from both the cerebrum
(marked with B) and the cerebellum (marked with b) of brains of
infected mice. The lane marked “v” is the positive control taken
from a cultured virus suspension.
Figure 2 Pathological changes with severe inflammation in a
mouse brain infected with Japanese encephalitis virus. (A)
Inflammatory infiltrate around the vessel in the brain. The blood
vessel is congested with inflammatory cells. (B) Degenerating
neurons (pink) shown in the brain of symptomatic mice are being
engulfed by phagocytes (arrow). Hematoxylin and Eosin staining.
Original magnification: × 400.
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disability after a period of 21 d. Of these, 3 (3/6; 50%) of
the symptomatic and 1 (1/15; 6.67%) of the asympto-
m a t i cm i c ew e r ep o s i t i v ef o rt h eM B P - s p e c i f i ca n t i b o d y
(Table 1). The OD value from mice with symptoms was
0.076 ± 0.019, which was significantly higher than that
from the asymptomatic mice (0.057 ± 0.005) (Student’s
t test; p < 0.05) (Figure 4).
MBP-specific T cell proliferation in response to JE viral
infection
To assess proliferation of specific T cells, mice infected
with the JE virus were administrated 50 μg/ml MBP.
The results showed that stimulation indexes (SIs), used
to express the efficacy of T-cell proliferation, for three
mice with symptoms (s1~s3) were 1.53, 1.66, and 2.70,
respectively. In contrast, values were 0.61 and 0.79,
respectively, for the two asymptomatic mice and 1.16
and 0.99, respectively, for the two control mice (inocu-
lated with culture medium) (Figure 5). It was shown
that higher SIs generally occurred in symptomatic mice
compared to control and asymptomatic mice.
Discussion
In a mouse model, intravenously inoculated JE virus
migrates into the brain within 2 d after inoculation,
causing the brain to become infected by the invading
virus [10]. Both the cerebrum and cerebellum are fre-
quently infected; in most cases, the cerebrum becomes
infected earlier and more intensely [9]. Due to impair-
ment of the BBB, alterations of tight junctions of capil-
laries in the CNS are believed to be the entrance route
of inflammatory cells into the parenchyma of the brain
[11,21]. This usually results in inflammation of the CNS
[8] and causes cellular destruction as well [22].
The present results showed that demyelination com-
monly occurs in the brain of mice with JE virus
Figure 3 D e m y e l i n a t i o ns h o w ni nt h eb r a i no fm i c ei n f e c t e d
with the Japanese encephalitis virus. (A) Severely demyelinating
axons extensively distributed in the brain, primarily the cerebrum, of
symptomatic mice. (B) Demyelinated axons present a loose
composition of myelin. (C) Normal axons were surrounded by a
myelin sheath that was condensed with intraperiodic lines. Scale
bar = 5 μm for A, 500 nm for B, and 100 nm for C.
Table 1 Specific IgG antibody to myelin basic protein (MBP) detected in Japanese encephalitis virus-infected mice that
did or did not exhibit symptoms during a period of 21 days of observation
Symptoms Number of observations Number positive
† Mean ± SD Statistics*
+ 6 3 (50%) 0.076 ± 0.019 p < 0.05
- 15 1 (6.67%) 0.057 ± 0.005
†Being positive was determined by the criterion of being higher than the sum of the average optical density (OD) value and 2 standard deviations (SDs) of the
control group.
*Student’s t-test at a 5% level of significance.
Figure 4 Detection of an anti-MBP antibody in mouse sera
collected from JE virus-infected mice. Average titers of the anti-
MBP antibody (IgG) from mice with impaired movement were
significantly higher than those in asymptomatic ones (Student’s
t-test, p < 0.05). S, Sera from symptomatic mice; AS, sera from
asymptomatic mice.
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brain that is infected by encephalitis viruses as seen in
patients with HIV infection [23]. It is the process by
which axons lose myelin that normally serves as an
insulator, resulting in loss of balance and coordination,
although it may vary among patients [24]. While the
causes of demyelination in the CNS remain unclear, var-
ious aspects were widely investigated such as in multiple
sclerosis (MS) and viral infections, e.g., canine distemper
virus [25] and mouse hepatitis virus [26]. Despite further
evidence being expected, MS usually results in major
disability and is now linked to viral infection, most likely
Epstein-Barr virus (EBV) [27].
In the CNS of mammals, oligodendrocytes, constitut-
ing glial cells with microglia and astrocytes, are myelin-
forming cells [28]. Injury to oligodendrocytes which end
up undergoing apoptosis was postulated to be responsi-
ble for myelin destruction and subsequent demyelina-
tion [29]. Our observations showed that the JE virus
normally infects neurons and astrocytes. However, most
oligodendrocytes in the brains of those mice remained
intact and uninfected [9]. Presumably, factors other than
virus-induced oligodendrocyte damage may play an
essential role in the occurrence of demyelination. Neu-
ronal death which is widely seen in JE virus-infected
mouse brain is probably important for induction of axo-
nal injury and demyelination [30]. Many other mos-
quito-borne encephalitic viruses such as Sindbis virus
(SV) are reported to be associated with death of neuro-
nal cells [15], which possibly is the first step in the
demyelination process.
It is interesting to identify factors that are responsible
for structural destruction of myelin surrounding axons.
Virus-mediated autoimmunity seen in MS and Theiler’s
virus infection was reported to cause T cell-mediated
autoimmune disease related to demyelination [31,32].
Guillain-Barré syndrome, characterized by widespread
dysfunction of peripheral nerves, may appear and cause
acute inflammatory demyelinating polyneuropathy in JE
patients [33]. According to our results, a myelin-specific
autoimmune response might be a relatively important
cause of demyelination among JE patients and with
other viral infections [34,35].
The present study revealed that the proliferation of
MBP-specific T-lymphocytes increases during JE viral
infection. This likely induces a cascade of destruction of
the axon-surrounding myelin. Because MBP-specific
antibodies are also present in some asymptomatic mice,
it seems that MBP is probably not the only target which
can trigger autoimmunity against myelin. Other compo-
nents of myelin including proteolipid protein (PLP) and
myelin oligodendrocyte glycoprotein (MOG) are also
known to be capable of eliciting specific antibodies in
MS patients [36], suggesting the possibility of causing
myelin destruction and the resulting demyelination. It
was concluded that the JE virus which normally causes
inflammation and neuronal degeneration in the CNS
induces proliferation of specific T cells which mediate
autoimmunity to destroy components of axon-surround-
ing myelin such as MBP.
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